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SUMMARY
Studies on anthelmintic resistance in equine parasites do not include facultative parasites.Halicephalobus gingivalis is a free-
living bacterivorous nematode and a known facultative parasite of horses with a strong indication of some form of tolerance
to common anthelmintic drugs. This research presents the results of an in vitro study on the anthelmintic tolerance of several
isolates ofHalicephalobus to thiabendazole and ivermectin using an adaptation of theMicro-Agar Larval Development Test
hereby focusing on egg hatching and larval development.Panagrellus redivivus andPanagrolaimus superbuswere included as
a positive control. The results generally show that the anthelmintic tolerance of Halicephalobus to both thiabendazole and
ivermectin was considerably higher than that of the closely related Panagrolaimidae and, compared to other studies, than
that of obligatory equine parasites. Our results further reveal a remarkable trend of increasing tolerance from fully free-
living isolates towards horse-associated isolates. In vitro anthelmintic testing with free-living and facultative parasitic
nematodes oﬀers the advantage of observing drug eﬀect on the complete life cycle as opposed to obligatory parasites that can
only be followed until the third larval stage. We therefore propose Halicephalobus gingivalis as an experimental tool to
deepen our understanding of the biology of anthelmintic tolerance.
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INTRODUCTION
To date, studies on anthelmintic resistance or
tolerance in equine parasites only include obligatory
parasites, not facultative parasites. Halicephalobus
gingivalis (Stefánsky, 1954, Andrássy, 1984) also
referred to as H. deletrix or as Micronema deletrix
(Anderson et al. 1998), is a small (235–460 μm) free-
living bacterivorous nematode (Panagrolaimidae)
and a known facultative parasite of horses (Blunden
et al. 1987; Nadler et al. 2003) and zebra (Isaza et al.
2000). In addition, 4 cases of human infection, all
with a fatal outcome, have been described (Ondrejka
et al. 2010).H. gingivalis has all the characteristics of
a free-living nematode, only at the ultrastructural
level can some potential adaptations to facultative
parasitism be observed (Fonderie et al. 2009).
Infection probably occurs through open wounds
and oral or nasal cavities (Pearce et al. 2001).
Subsequently, nematodes most likely invade the
bloodstream and lymphatic system and thus reach
diﬀerent organs (e.g. kidneys, liver and brain) where
the number of nematodes increases rapidly through
parthenogenetic reproduction (Akagami et al. 2007).
The clinical symptoms vary depending on which
organs are infected (Blunden et al. 1987; Spalding
et al. 1990; Rames et al. 1995; Johnson et al. 2001;
Müller et al. 2008). A few cases have been described
in which the infection was recognized in time and the
horse was successfully treated (Dunn et al. 1993;
Pearce et al. 2001; Müller et al. 2008). Still, most
infections were only recognized post-mortem after a
thorough autopsy. Most importantly, the clinical
histories of all reported equine infections show that
the horses had been regularly treated with common
anthelmintics (e.g. Boswinkel et al. 2006, Ferguson
et al. 2008). This strongly indicates thatH. gingivalis
either has a high tolerance or some form of resistance
to these anthelmintic drugs.
The current paper presents the ﬁrst research on
anthelmintic tolerance of the facultative parasitic
nematode Halicephalobus gingivalis. Several isolates
were tested for tolerance to common anthelmintic
drugs through in vitro experiments focusing on egg
hatching and larval development. Both free-living
and parasitic isolates were included to examine
whether tolerance is restricted to parasitic isolates or
whether it also holds true for free-living isolates. The
results on the H. gingivalis isolates were compared
with those on the closely related free-living nematode
species Panagrellus redivivus and Panagrolaimus
superbus, allowing us to discriminate species- or
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strain-speciﬁc tolerance from any more general
tolerance in the free-living Panagrolaimidae.
MATERIALS AND METHODS
Maintenance of cultures
We selected 4 isolates for our experiments. Theywere
all light-microscopically identiﬁed as the morpho-
species Halicephalobus gingivalis using diﬀerent
identiﬁcation keys (Geraert et al. 1988; Shokoohi
et al. 2007). No males were observed conﬁrming that
this species is parthenogenetic (Stefansky, 1954;
Andrássy, 1984; Akagami et al. 2007; Fonderie
et al. 2009). The JB128 isolate was obtained from a
vegetable compost heap in Riverside (California,
USA). The WB0708 isolate was obtained from a
large-scale compost heap (Steel et al. 2010) at the
Institute for Agricultural and Fisheries Research in
Merelbeke (Belgium). The WB0801 isolate was
obtained from fresh horse droppings from an
individual stall on a stable in the province of West-
Flanders (Belgium). The SAN100 isolate is a clinical
isolate originating from an infection in a horse
(Guelph, Ontario, Canada) described by Anderson
et al. (1998). SAN100 has been maintained in culture
on plain bacteriological agar with a bacterial food
source since its isolation. Hence, we used 2 compost
isolates from horse-independent habitats and 2
isolates from horse-associated habitats including 1
parasitic isolate and 1 isolate found in the near
vicinity of horses. Two closely related free-living
species, Panagrellus redivivus PS1163 and Panagro-
laimus superbus DF5050, were included in the ex-
periments to discriminate species- or strain-speciﬁc
tolerance from a possible more general tolerance in
the otherwise free-living Panagrolaimidae.
Stock cultures of all species were maintained on 1%
bacteriological agar (Oxoid, Basingstoke, UK) plates
containing cholesterol (1 mgml−1) and Escherichia
coli OP50 as a food source. The stock cultures were
incubated at 20 °C and generally handled as described
by Brenner (1974). To provide enough eggs to start
the experiments, the Halicephalobus isolates were
subcultured and incubated at 37 °C for 3 to 4 days. At
this temperature the cultures grow fast and numerous
eggs can be generated over a short period of time. The
P. redivivus and P. superbus isolates were subcultured
2 weeks beforehand and incubated at 20 °C to yield a
suﬃcient amount of eggs.
Anthelmintics
The anthelmintics used in the experiments were
thiabendazole (TBZ; Sigma-Aldrich, Bornem,
Belgium) and ivermectin (IVM) that represent
members of 2 important anthelmintic groups, the
benzimidazoles and the avermectin/mylbecins,
respectively. They were selected because of the use
of products of these groups on the location where the
WB0801 isolate was found. TBZ is the most soluble
member of the benzimidazole group that facilitates
in vitro experiments. The IVM used in the exper-
iments are dilutions of Ivomec® Injection (Merial,
Brussels, Belgium), a commercially used form of the
drug.
Experimental setup
The technique used was a modiﬁcation of the micro-
agar larval development test (MALDT) (Coles et al.
2006). TheMALDTmethodwas originally designed
as a larval development test (LDT) on a solid instead
of in a liquid medium. MALDT was chosen over
LDT because of the ease of culturingHalicephalobus
on solid medium and because this very small
nematode is easier to discern on solid than in liquid
medium. The main objective of any larval develop-
ment test is to follow the development of nematode
eggs onto third-stage larvae, which generally is the
infective stage in obligatory animal parasites. Herewe
mainly focused on quantitative hatching data and
development to the adult stage.
The experiments were performed on 24-well plates
(Greiner Bio-One, Frickenhausen, Germany). The
anthelmintics were dissolved in 100% dimethylsulf-
oxide (DMSO; Carl Roth GmbH, Karlsruhe,
Germany). Five stock solutions of TBZ (100, 1000,
2000, 5000, 10000 μgml−1) and 5 stock solutions of
IVM (1, 10, 50, 100, 200 μgml−1) were prepared.
Stock solutions were diluted 100x by adding 49·5 ml
of 1% bacteriological agar at approximately 45 °C to
0·5 ml of drug solution in a 50ml Falcon ﬂask. The
ﬁnal solution was carefully homogenized before
adding 3ml to each well. The control consisted
of 1% bacteriological agar with a ﬁnal concentration
of 1% DMSO. We chose to keep the concentration of
DMSO in the ﬁnal solutions at 1% to exclude any
inﬂuence on the mortality rate as reported for
Caenorhabditis elegans by Ura et al. (2002) for
DMSO concentrations in excess of 5%. Final drug
concentrations in the wells were 1, 10, 20, 50 and
100 μgml−1 for TBZ and 0·01, 0·1, 0·5, 1·5, and 2 μg
ml−1 for IVM. Initially, the Halicephalobus isolates
were tested against a range of drug concentrations
based on Várady et al. (2009). Because only small to
no eﬀects were noticed, higher concentrations were
chosen in the present experiments.
The tests were performed in 3 replicates for each
anthelmintic concentration with the zero concen-
tration as a negative control. Approximately 50
nematode eggs were transferred into each well. The
exact number of eggs was counted for each well. The
plates were subsequently incubated at an optimal
temperature for development, i.e. 30 °C for the
Halicephalobus isolates and 20 °C for P. redivivus
and P. superbus. Hatching was quantiﬁed at the time
eggs normally develop into the adult stage, which is
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after 48 h incubation at 30 °C for the Halicephalobus
isolates and after 7 days incubation at 20 °C for
P. redivivus and P. superbus. In order to assess the
reproducibility of our bioassay, we repeated the entire
experiment 15 months after the ﬁrst trial.
The hatching proportion (HP) is calculated for
each well as follows: the number of hatched eggs and
surviving larvae or adults is divided by the number of
eggs originally transferred onto the agar. This
proportion is determined at each concentration.
Moreover, in contrast to TBZ which prevents both
embryonation and hatching of nematode eggs
(Taylor et al. 2002), IVM mainly has an eﬀect on
the larval stage and only prevents hatching at very
high concentrations (Patel, 1997). Therefore, an
experiment was performed to verify whether larval
stages surviving high IVM concentrations but
initially not developing into the adult stage, can
overcome the eﬀect of drug treatment and resume
development. To this end, 3 replicas of 40 eggs of
each Halicephalobus isolate were transferred onto 1%
bacteriological agar containing 1·5 μgml−1 IVM and
were incubated at 30 °C. After 76 h, 20 surviving
larvae of each replicate were transferred onto plain 1%
bacteriological agar and observed for several days.
Their recovery rate is deﬁned as the number of
transferred larvae that develop into the adult stage
divided by the number of initially transferred larvae
×100.
Eﬀect of pre-exposure on anthelmintic tolerance
Anthelmintic tolerance can be caused or increased by
contact of the nematodes with the anti-parasitic drug
in question. In order to verify the short-term eﬀect of
a prior anthelmintic treatment on the anthelmintic
tolerance ofHalicephalobus cf. gingivalis, all 4 isolates
(JB128, WB0708, SAN100 and WB0801) were
cultured for approximately 12±2 generations at
30 °C on 1% bacteriological agar containing a low
dose of anthelmintics, i.e. 10 μgml−1 TBZ or 0·01
μgml−1 IVM. After this period, the modiﬁcation of
the MALDT method was performed as described
above, leaving out the lowest TBZ concentration of
1 μgml−1.
Statistical analysis
To test for diﬀerences in the response of the isolates
towards each anthelmintic across the two trials, the
data were modelled by means of a generalized linear
mixed model (PROC GLIMMIX in SAS® v.9.3,
SAS Institute Inc., Cary, NC, USA). As we were
merely interested in the eﬀect of ‘isolate’ and
‘concentration’ and their interaction, these factors
were treated as ﬁxed eﬀects in the model. Yet, as the
whole experiment was replicated in 2 trials, the ﬁxed
eﬀects were assessed across both trials by including
the factor ‘trial’ as random eﬀect in the model. As the
response variable includes the number of hatched or
survived individuals on the total number of individ-
uals, a binomial error distribution was assumed and
a logit link was incorporated to relate the predictive
part of the model to the mean response. Standard
error and degrees-of-freedom were estimated accord-
ing to the method described by Kenward and Roger
(1997). Signiﬁcance of the ﬁxed eﬀects and their
interactions were tested by means of Type III
tests. Diﬀerences in tolerance between the isolates
were post-hoc tested by comparing the expected
hatching success and survival probability at diﬀerent
concentrations (least square means), using a Tukey-
Kramer-adjustment to correct for multiple testing.
Given that generalized linear mixed models are
large sample tests (Agresti, 2002), we did not rely on
this procedure to compare the eﬀect of the anthel-
mintics between the Halicephalobus isolates and
P. redivivus and P. superbus as their hatching
proportion approached zero at higher concentrations.
Therefore, a Fisher exact test procedure was used for
these comparisons as implemented in StatXact® v.5.0
(Cytel Inc., Cambridge, MA, USA).
The eﬀect of pre-exposure to anthelmintics was
analysed using Statistica 7 (StatSoft Europe GmbH,
Hamburg, Germany) for each Halicephalobus isolate
separately using two-way analysis of variance
(ANOVA) with the factors anthelmintic concen-
tration and pre-exposure, followed by a post-hoc
Tukey HSD test. The assumptions for ANOVA
(normality and homogeneity of variances) were tested
using a Kolmogorov-Smirnov test and a Bartlett test,
respectively.
RESULTS
Thiabendazole (TBZ)
Figure 1 shows the mean hatching proportions (HPs)
of the Halicephalobus isolates and of P. redivivus
and P. superbus for both trials at diﬀerent TBZ
concentrations, with 0 μgml−1 being the negative
control. The mean HPs of the negative controls were
comparable for the parasite isolate, the droppings
isolate, P. redivivus and P. superbus, with an
average ranging from 0·96 to 0·99. However, the
HPs of the negative controls of the compost isolates,
with an average ranging from 0·91 to 0·93, were
signiﬁcantly (Tukey post-hoc, P<0·0001) lower
than those of the parasite isolate and the droppings
isolate.
The response of P. redivivus and P. superbus to
TBZ concentration was similar in both trials; they
had an initially highHPwith an average ranging from
0·85 to 0·94 at 1 μgml−1 followed by a steep decrease
towards zero hatching at 10 μgml−1 and higher TBZ
concentrations. From 10 μgml−1 onwards, the HPs
of both P. redivivus and P. superbuswere signiﬁcantly
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lower than those of allHalicephalobus isolates (Fig. 1;
Fisher’s exact test: P all <0·0001).
Besides an overall signiﬁcant negative eﬀect on the
HPs of all the Halicephalobus isolates, signiﬁcant
diﬀerences were observed in their mean HP (‘Isolate’
eﬀect), as well as in their response towards TBZ
concentration across trials (Isolate*concentration
eﬀect) (Table 1). Comparison of the meanHPs across
trials revealed that the parasite isolate had the highest
average HPs, which were signiﬁcantly diﬀerent
from the average HPs of the droppings isolate
(Tukey post-hoc,P all <0·05) and fromboth compost
isolates at all TBZ concentrations (P all <0·0001).
The droppings isolate had the second highest average
HPs, which were also signiﬁcantly higher than the
average HPs of both compost isolates at all drug
concentrations (P all <0·0001). Compost isolates 1
and 2 had the overall lowest average HPs of the
Halicephalobus isolates, without signiﬁcant (P all
>0·07) mutual HP diﬀerences.
Ivermectin (IVM)
The mean HPs of the Halicephalobus isolates and of
P. redivivus and P. superbus of both trials at the
diﬀerent IVM concentrations are shown in Fig. 2,
with 0 μgml−1 being the negative control. The
average HPs of the negative controls were similar
for all Halicephalobus isolates and for P. redivivus
and P. superbus with an average HP ranging from
0·92 to 1.
As for TBZ, the HPs of both P. redivivus and
P. superbus soon dropped signiﬁcanty lower (at
0·1 μgml−1) compared to those of theHalicephalobus
isolates (Fisher’s exact test: P all <0·0001). As the
HPs for both P. redivivus and P. superbus even
approached zero for IVM concentrations that were
higher than 0·5 μgml−1, they were signiﬁcantly lower
compared to the HPs of the Halicephalobus isolates
for all the remaining IVM concentrations (Fisher’s
exact test: P all <0·0001).
Also for IVM, within the Halicephalobus isolates
signiﬁcant diﬀerences were observed in both the
mean hatching rate and in their response to IVM
concentration across both trials (Table 1). The
average HPs of the parasite isolate were also the
highest at all IVM concentrations, followed by those
of the droppings isolate and subsequently those of
compost isolate 1. Although they were not clearly
separated, they were signiﬁcantly diﬀerent from each
Table 1. Type III statistics of ﬁxed eﬀects generated by means of a generalized linear mixed model on the
average hatching proportions (HPs)
Eﬀect
TBZ IVM
F value P F value P
isolate 85 <0·0001 64 <0·0001
concentration 604 <0·0001 275 <0·0001
concentration*isolate 5·8 <0·001 7·3 <0·0001
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Fig. 1. The hatching proportion (HP) for all Halicephalobus cf. gingivalis isolates† and for Panagrellus redivivus
(PS1163) and Panagrolaimus superbus (DF5050) at diﬀerent thiabendazole (TBZ) concentrations (μgml−1). Data
represent the mean of 3 replicates (±1 S.D.) for 2 independent and consecutive trials. Data from the second trial are
indicated (2nd). †Compost isolates, i.e. compost 1 (WB0708) and compost 2 (JB128); horse-associated isolates,
i.e. parasite (SAN100) and droppings (WB0801).
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other (P all <0·02), except for the average HPs of
the droppings isolate and compost isolate 1 from
1·55 μgml−1 onwards (P all >0·06). Compost isolate
2 had the overall lowest average HPs, which were
signiﬁcantly lower than the average HPs of the other
Halicephalobus isolates at all IVM concentrations
(Tukey post-hoc, P all <0·0001).
Recovery capacity after drug treatment
TBZ treatment showed a dose-related inhibitory
eﬀect on egg hatching for the Halicephalobus isolates
and forP. redivivus andP. superbus.However, the eggs
that hatched show no discernible delay in develop-
mental rate at all TBZ concentrations, and almost all
the hatched larvae developed into the adult stage. In
contrast, for the tested IVM concentrations the
inhibitory eﬀect on egg hatching was less explicit.
Only little inﬂuence on hatching was observed
compared to the negative controls and the develop-
mental rate of the eggs at the diﬀerent IVM
concentrations was the same. However, there was a
dose-related eﬀect on the survival of the juveniles and
at higher IVM concentrations there was a noticeable
delay in the development of the juveniles into
the adult stage. At 0·01 μg ml−1 IVM concentration
the adult stage of all H. gingivalis isolates and
P. redivivus and P. superbus was attained with a delay
of 24 to 48 h. At 0·5–2 μgml−1 IVM, the larvae of the
Halicephalobus isolates survived, with a reduced
motility, but did not develop into the adult stage.
However, this negative eﬀect on larval development
was found to be reversible for the parasite isolate,
the droppings isolate and compost isolate 1.
Hatched larvae incubated for 76 h onwells containing
1·5 μgml−1 IVM had a survival rate of 85·4±4·5%
(mean±1S.D.) for the parasite isolate, 71·6±2·5% for
the droppings isolate and 75·8±4·6% for compost
isolate 1. Surviving larvae were subsequently trans-
ferred onto 1% plain bacteriological agar whereupon
they reached the adult stage after 3 days.The recovery
rate was 94·1±2·3% (mean ±1 S.D.) for the parasite
isolate, 77·9±5·7% for the droppings isolate and
91·1±5·1% for the compost isolate 1. Compost isolate
2 only had 16·5±4·5% surviving larvae, which did not
develop into the adult stage after transfer onto plain
1%bacteriological agar.Finally, this recovery capacity
could not be tested for P. redivivus and P. superbus at
1·5 μgml−1 IVM since there were no surviving larvae
at higher IVM concentrations.
Inﬂuence of pre-exposure on anthelmintic tolerance
The eﬀect of pre-exposure with anthelmintics for
approximately 12 generations was very similar for all
isolates and is therefore only illustrated for compost
isolate 1 (Fig. 3). For both anthelmintics, the HPs of
all Halicephalobus isolates in the control treatment
were signiﬁcantly lower (Tukey post-hoc, P<0·001)
upon pre-exposure as opposed to the HPs of eggs
deposited by nematodes which had not been pre-
exposed, i.e. 10–20% and 37–47% lower for IVM and
TBZ, respectively. The dose-response upon pre-
exposure was nevertheless diﬀerent between TBZ
and IVM.
Upon pre-exposure to TBZ, the HPs exhibited
limited (compost isolate 2) to no (compost isolate 1,
parasite isolate, droppings isolate) concentration
dependence, which was demonstrated by the lack of
signiﬁcant diﬀerences (Tukey post-hoc, P all >0·05)
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Fig. 2. The hatching proportion (HP) for all Halicephalobus cf. gingivalis isolates† and for Panagrellus redivivus
(PS1163) and Panagrolaimus superbus (DF5050) at diﬀerent ivermectin (IVM) concentrations (μgml−1). Data represent
the mean of 3 replicates (±1 S.D.) for 2 independent and consecutive trials. Data from the second trial are indicated
(2nd). †Compost isolates, i.e. compost 1 (WB0708) and compost 2 (JB128); horse-associated isolates, i.e. parasite
(SAN100) and droppings (WB0801).
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between the HPs at diﬀerent drug concentrations,
including the control.
Upon pre-exposure to IVM the HPs still showed a
similar concentration dependence as opposed to non-
pre-exposure. However, for most isolates (compost
isolate 1, parasite isolate, droppings isolate) the HPs
at all concentrations were signiﬁcantly lower (P all
<0·05) than in the original experiment, except the
HPs of compost isolate 2 that showed no signiﬁcant
diﬀerence (P>0·05) at all concentrations.
DISCUSSION
Methodological considerations
Several methodological aspects may bear upon
the results of dose-eﬀect studies like the present
one. We are, however, convinced that the methods
used here allow an accurate assessment of the eﬀect of
the anthelmintics used in this study. The MALDT
method has been proven earlier to give reliable results
concerning the detection of benzimidazole resistance
(Várady et al. 2009), and by using this agar-based
method the insolubility problem of IVM is elimi-
nated (Lacey et al. 1991). Moreover, former studies
have revealed that the activity of IVM incorporated
in agar is higher than in aqueous solutions (Várady
et al. 2009). Secondly, our negative controls of
the Halicephalobus isolates, P. redivivus and of
P. superbus have HPs close to 100%. Therefore it
can be assumed that the incubation conditions used
here are adequate. Thirdly, the steep decrease of the
HPs of P. redivivus and P. superbus compared to the
relatively high HPs of the Halicephalobus isolates at
higher concentrations of both TBZ and IVM
conﬁrms that eﬀective drug treatment is detectable
using this method. Finally, the highly concordant
results of 2 independent experimental trials demon-
strate the reproducibility of our bioassay.
Tolerance versus resistance
It is very important to distinguish between an
original low, or lack of, eﬀectiveness of an
anthelmintic drug to a population and the presence
of actual resistance to that same anthelmintic (Brady
and Nichols, 2009). The lack of eﬀectiveness can be
seen as an existing natural tolerance to an anthelmin-
tic even before the parasite has come in contact with
the drug (Fallon et al. 1996; Coles, 2006), whereas
acquired resistance is the conversion within a species
of a low or absent tolerance towards a higher tolerance
which is initiated by contact with the anthelmintic
(James et al. 2009). The overall high hatching
proportions of the Halicephalobus isolates at all
concentrations tested in this study suggest the
presence of some kind of natural tolerance to IVM
and TBZ. This tolerance appears speciﬁc for the
facultative parasitic genus Halicephalobus, since in at
least some Panagrolaimidae (P. redivivus and
P. superbus) no tolerance was observed. The stunning
tolerance of the Halicephalobus isolates to TBZ and
IVM is further conﬁrmed by the considerably higher
concentrations (roughly 75 times the maximum dose
used for TBZ and roughly 45 times the maximum
dose used for IVM) used in the present study as
compared to TBZ and IVM concentrations used in
another in vitro study using the MALDT method
for testing anthelmintic resistance of the obligatory
parasite Haemonchus contortus (Várady et al. 2009).
Our results reveal that the horse-associated
Halicephalobus isolates are highly tolerant for both
tested anthelmintic drugs and that theHalicephalobus
compost isolates show an anthelmintic tolerance
that is generally lower. Thus, our results also reveal
a remarkable trend of increasing tolerance from
fully free-living isolates towards horse-associated
isolates, which is especially true for TBZ. This
diﬀerence in tolerance to anthelmintics between the
Halicephalobus isolates may be associated with earlier
contact to these anti-parasitic drugs. However, none
of the Halicephalobus strains have been found to be
fully susceptible to either anthelmintic. Since there is
no fully susceptible strain available, no actual
acquired resistance can be proven (Brady and
Nichols, 2009). In addition, the pre-exposure exper-
iments did not show a decreased susceptibility to the
non-exposed
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Fig. 3. The mean hatching proportion (HP) of pre-exposed eggs (dotted line) is compared with the mean HPs of
non-exposed eggs (full line) for Halicephalobus compost isolate 1 (WB0708) at diﬀerent TBZ (a) and IVM (b)
concentrations (μgml−1). Data represent the mean of 3 replicates (±1 S.D.).
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tested anthelmintics. The average HPs of all pre-
exposed isolates in the control treatment (no anthel-
mintic added) were considerably lower (by 10–47%)
than those of non-pre-exposed nematodes, which
indicates that the ﬁtness of all isolates is negatively
aﬀected by prolonged exposure to the anthelmintics,
resulting in a lower egg viability. This type of
negative eﬀect of a chemical compound on nematode
egg viability has been shown earlier for e.g. tannins
on gastro-intestinal parasites (Min and Hart, 2003).
Further, the HPs under anthelmintic exposure
exhibited only limited (compost isolate 2) to no (the
other isolates) concentration dependence for TBZ
and similar (compost isolate 2) or generally lower
HPs (the other isolates) for IVM. This is contrary to
the idea that the high tolerances observed in short
exposure experiments and the diﬀerences between
the horse-associated and the other isolates would be
due to a true resistance. Moreover, diﬀerences in the
D2D3 expansion segment of the LSU rDNA region
(data not shown) shows a remarkable interpopulation
variation. However, phylogenetic analyses, including
GenBank (Benson et al. 2008) sequences, appointed
our Halicephalobus isolates (WB0801, GenBank
HQ697251 and WB0708, GenBank JF706244)
within an internally unresolved H. gingivalis clade
(data not shown). Light microscopically, they are not
discernible from other H. gingivalis isolates (JB128
and SAN100) and should therefore be referred to as
Halicephalobus cf. gingivalis. Most likely, biological
diﬀerences including anthelmintic tolerance between
the Halicephalobus isolates are associated with diﬀer-
ent evolutionary lineages or cryptic species as
indicated by these D2D3 sequence diﬀerences.
Finally, since even the very high anthelmintic
concentrations used in the present study appear
ineﬀective to control the Halicephalobus isolates and
since IVM administered to horses at the rec-
ommended dosage has a maximum plasma persis-
tence of 4 to 62 ngml−1 (Gokbulut et al. 2010), it is
very unlikely that in vivo anthelmintic treatments are
eﬀective for infections with this facultative parasite.
This is supported by the medical history of horses
that suﬀered lethal infections of this nematode
species in spite of regular treatment with common
anthelmintics (e.g. Boswinkel et al. 2006, Ferguson
et al. 2008).
Halicephalobus as a model organism
In research on the eﬀects of anti-parasitic drugs, the
use of free-living nematodes for in vitro experiments
has the advantage of allowing observations on their
complete life cycle, including survival and (delayed)
development. In contrast, obligatory animal parasites
can only be followed until the infective stage.
Caenorhabditis elegans has been used as a model for
studies on the development of anthelmintic resistance
and the testing of the eﬃciency of new drugs (e.g.
Simpkin and Coles, 1980; Sangster et al. 2002; James
and Davey, 2009). Since its complete genome is
known, C. elegans is especially suitable for studying
the eﬀects of anthelmintics at the gene level (Holden-
Dye and Walker, 2007). However, the usefulness of
C. elegans as a model for parasitic nematodes has been
questioned (Geary and Thompson, 2001), among
other reasons simply because it is not capable of
parasitism in its natural environment.Halicephalobus
gingivalis shares several of the advantages of
C. elegans as a model organism: it is amenable to
culture under laboratory conditions; it has a very
short generation time (2 days at 30 °C), produces a lot
of oﬀspring, can be cultured in liquid (monoxenic as
well as axenic) as well as on solid media (Fonderie
et al. 2009) and at temperatures ranging from 4 °C to
more than 40 °C (personal observations, unpublished).
Additionally,H. gingivalis is capable of parasitism in
its natural environment. Moreover, since complete
genome sequencing is nowadays relatively fast and
easy (Elsworth et al. 2011), the ‘genetic barrier’ can
easily be overcome. Although the lack of a susceptible
isolate is a drawback to the use of Halicephalobus cf.
gingivalis as a model organism for testing new
anthelmintics, the presence and ease of cultivation
of susceptible close relatives such as Panagrellus and
Panagrolaimus provides great potential as an exper-
imental tool for testing the eﬀects of various drugs on
a model system encompassing a range of tolerances
and including an organism with a life-history
intermediate between that of obligatory parasites
and of fully free-living nematodes.
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